Morgan Stanley raises its rating on GenOn Energy GEN from Underweight to Equal-weight and increases its price target from $1.20 to $1.40.
Morgan Stanley comments, "GenOn has substantially underperformed its peers, with a 49% price drop YTD. While we remain cautious, we are upgrading to Equal-weight based on our sum-of-parts valuation. Equity benefit from further cost reductions is unusually high for GenOn, with ~80% upside from a 10% cost reduction."
GEN closed at $1.33 on Friday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in